Latest Release of TrialAssure ANONYMIZE for Documents Saves up to 80 Percent of Effort in PDF Document Anonymization and Redaction for Regulated Pharmaceutical Industry Documents
CANTON, Mich. (November 19, 2020) – TrialAssure® has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently. Leveraging the power of the cloud for processing, this software has been shown to save as much as 80 percent of the effort involved in the redaction and anonymization process for PDFs based on flexible and reusable rule setting features – as compared to traditional manual redaction.
FORMER GILEAD SCIENCES HEAD OF CLINICAL TRIAL DISCLOSURE AND DATA TRANSPARENCY JOINS MMS AND TRIALASSURE AS DIRECTOR OF GLOBAL TRANSPARENCY STRATEGY AND COMPLIANCE
CANTON, Mich. (April 16, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the addition of Kelly Vaillant as Director, Global Transparency Strategy and Compliance. Vaillant will lead the transparency and compliance efforts across MMS and TrialAssure global operations. TrialAssure is the technology arm of MMS and a leading, global software company focused on advancing clinical trial transparency.
TRIALASSURE TRANSPARENCY SUITE WINS DATA SOLUTION OF THE YEAR—HEALTHCARE IN THE 2020 DATA BREAKTHROUGH AWARDS
CANTON, Mich. (April 10, 2020) – TrialAssure® – the technology arm of MMS and leading, global software company focused on advancing clinical trial transparency – has won the “Data Solution of the Year—Healthcare” award in the 2020 Data Breakthrough Awards. Among a field of 1,500 applicants from around the globe, the TrialAssure transparency suite was recognized for its excellence in clinical trial registration, trial disclosure, clinical data sharing, anonymization of documents and datasets, and plain language summary applications.
As Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency Tool
CANTON, Mich. (April 7, 2020) – TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today that it will offer academic institutions free access to TrialAssure REGISTRY—the premiere clinical trial disclosure reporting application. This offer is limited to the registry configurations for ClinicalTrials.gov, the US Food & Drug Administration (FDA) clinical trial registry, and it includes one upgrade per year, keeping with technological advancements and any US regulatory updates or changes to registry requirements.
I would like to take a moment and share our commitment to the highest levels of health and improving lives worldwide, amidst the outbreak of COVID-19.
The health of our staff and yours around the globe is of the utmost importance to us. We also understand that the well-being, strengths and skills of our colleagues in the United States, Europe, India, and South Africa are essential to the on-time delivery of every project. We are taking the necessary precautions to ensure that every colleague remains healthy, productive, and committed to supporting your efforts.
TrialAssure Launches First-in-Class Document Anonymization Tool Using Machine Learning and Artificial Intelligence to Protect Patient Data
Canton, Mich. (November 7, 2019) – TrialAssure® – a leading, global software company advancing clinical trial transparency tools – announced today the limited release of ANONYMIZE R, a first-in-class document anonymization software that uses machine learning, natural language processing, and artificial intelligence (AI) to protect patient privacy by automatically finding and removing personal information from text. The announcement was made during the American Medical Writer’s Association (AMWA) annual conference in San Diego, California.
TrialAssure’s ANONYMIZE DS Patient Data Anonymization Tool Built with Machine Learning is Now Publicly Available
BETHESDA, Md. (September 19, 2019) – TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today the full release of ANONYMIZE DS, the all-new software-as-a-service (SaaS) application that utilizes automation to anonymize sponsor’s clinical trial data, during the DIA Global Clinical Trial Disclosure and Data Transparency Conference. Gathering user feedback since its limited release in February 2019, TrialAssure ANONYMIZE DS is now fully available to the public.
TrialAssure launches TrialResults.com for Clinical Trial Sponsors to Publicly Post Plain Language Summaries
TrialResults.com helps lead the way in assisting clinical trial sponsors to #BeTransparent
AMSTERDAM and Canton, Mich. (June 11, 2019) – TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today the launch of TrialResults.com, a new portal for sponsors to publicly share plain language, or lay, summaries with clinical trial participants. This portal allows trial participants to access the plain language summaries in any region of the world and in their native language with ease, simultaneously reducing the burden for sponsors who do not have their own public portal.
Canton, Mich. (April 17, 2019) – TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today the launch of TrialAssure REGISTRY 2.5, the latest iteration of TrialAssure’s premiere clinical trial registration and disclosure reporting application with a configurable workflow engine that allows clients to augment regulatory intelligence for global registries.
Groundbreaking Transparency Application that Anonymizes Patient Data in Clinical Trials Launched by TrialAssure
Canton, Mich. (February 27, 2019) – TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today the limited release of ANONYMIZE DS, an all-new software-as-a-service (SaaS) application that allows sponsors to anonymize clinical trial data automatically. This exclusive application will be discussed during a presentation this afternoon by Zach Weingarden at the PhUSE Connect 2019 Data-Driven Science conference in Baltimore, Maryland.